Inventor · disambiguated record
Brian Granda
Also filed as: GRANDA BRIAN · GRANDA BRIAN WALTER
10 granted patents·18 pending applications·58 citations·filing 2007–2024
87Inventor score
Top patents by PatentIndex Score
28 records- 0196US10525083B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2017·Granted Jan 7, 2020·15 cites·33 claims
- 0294US11026976B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·6 cites·23 claims
- 0394US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 0493US11872249B2Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domainNOVARTIS AG·Filed 2021·Granted Jan 16, 2024·2 cites·38 claims
- 0584US12221481B2CD19 binding molecules and uses thereofNOVARTIS AG·Filed 2020·Granted Feb 11, 2025·2 cites·13 claims
- 0683US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 0780US12383601B2Chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted Aug 12, 2025·1 cites·21 claims
- 0880US12037378B2Variant CD58 domains and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 16, 2024·1 cites·16 claims
- 0979USRE49847ENucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2022·Granted Feb 27, 2024·0 cites·35 claims
- 1072US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1170US2025223359A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1268US11667691B2Treatment of cancer using chimeric CD3 receptor proteinsNOVARTIS AG·Filed 2016·Granted Jun 6, 2023·1 cites·44 claims
- 1366US2024083968A1Treatment of cancer using chimeric cd3 receptor proteinsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1456US2024002509A1ANTIBODY Fc VARIANTSNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1556US2025000973A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1655US2024309084A1Degradation of extracellular targetsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1753US2025215081A1Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignanciesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1850US2024025993A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1949US2023302155A1Compositions and methods for in vivo generation of car expressing cellsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2048US2023128499A1Bispecific combination therapy for treating proliferative diseases and autoimmune diseasesBIALUCHA CARL ULI·Filed 2021·Application pending·0 cites
- 2148US2022396631A1Trispecific binding molecules against bcma and uses thereofHUANG LU·Filed 2020·Application pending·0 cites
- 2247US2023256017A1Methods of making chimeric antigen receptor-expressing cellsBROGDON JENNIFER·Filed 2021·Application pending·0 cites
- 2345US2023037682A1Binding molecules against cd3 and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2445US2021163620A1Trispecific binding molecules against cancers and uses thereofGRANDA BRIAN·Filed 2019·Application pending·0 cites
- 2543US2020055948A1Cells expressing a bcma-targeting chimeric antigen receptor, and combination therapy with a gamma secretase inhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2639US2020362054A1Trispecific binding molecules against tumor-associated antigents and use thereofGRANDA BRIAN·Filed 2018·Application pending·0 cites
- 2738US2019375815A1Treatment of cancer using chimeric t cell receptor proteins having multiple specificitiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2837US2010015652A1Antibody quantitationGRANDA BRIAN WALTER·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Granda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →